JANE DAWSON: Open Payments
NPI 1679065858 · PALMETTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 27 payments from 10 companies in 2025. Trend: 2023 $191 · 2024 $148 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $225 |
| E.R. Squibb & Sons, L.L.C. | 4 | $169 |
| Otsuka America Pharmaceutical, Inc. | 3 | $156 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $140 |
| Janssen Pharmaceuticals, Inc | 2 | $73 |
| ABBVIE INC. | 2 | $54 |
| Indivior Inc. | 2 | $48 |
| Braeburn Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: COBENFY, Auvelity, CAPLYTA, LYBALVI, ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
